WealthShield Partners’s Genmab GMAB Stock Holding History

WealthShield Partners’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-46	Closed	-$2K	–	917
2021 Q1	$2K	Buy	+46	New	+$1.73K	﹤0.01%	1061

Other funds holding GMAB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

WealthShield Partners's GMAB Position: Q2 2021 in Review

WealthShield Partners sold out of Genmab (GMAB) in Q2 2021, closing a stake of 46 shares — an estimated $2K sold.

WealthShield Partners first reported a position in GMAB in Q1 2021 and held it in 1 quarter. The position peaked at $2K in Q1 2021. 212 funds tracked by Wall St. Rank hold GMAB as of Q2 2021.

WealthShield Partners reported no remaining Genmab position as of Q2 2021 after selling out during the quarter.
WealthShield Partners sold 46 Genmab shares in Q2 2021, an estimated $2K.
WealthShield Partners first reported a position in Genmab in Q1 2021 and held it in 1 quarter.
WealthShield Partners's Genmab position peaked at $2K in Q1 2021.
212 funds tracked by Wall St. Rank held Genmab as of Q2 2021.

Based on WealthShield Partners's 13F filing for Q2 2021, filed 6 Aug 2021.